CN102037005A - 改善治疗功效的新光学纯化合物 - Google Patents
改善治疗功效的新光学纯化合物 Download PDFInfo
- Publication number
- CN102037005A CN102037005A CN2008801293106A CN200880129310A CN102037005A CN 102037005 A CN102037005 A CN 102037005A CN 2008801293106 A CN2008801293106 A CN 2008801293106A CN 200880129310 A CN200880129310 A CN 200880129310A CN 102037005 A CN102037005 A CN 102037005A
- Authority
- CN
- China
- Prior art keywords
- lys
- aib
- gly
- pro
- peptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Heart & Thoracic Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Communicable Diseases (AREA)
Abstract
Description
氨基酸 | PyBOP/HOBt | DIC/HOBt | DIEA | |
Fmoc-Arg(Pbf)-OH | 12eq | 12eq/12eq | -- | 60eq |
Boc-Lys(Boc)-Ψ(CH2N-Pro)-OH | 9eq | -- | 9eq/9eq | -- |
Claims (14)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2008/053469 WO2009141687A1 (en) | 2008-05-22 | 2008-05-22 | New optically pure compounds for improved therapeutic efficiency |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102037005A true CN102037005A (zh) | 2011-04-27 |
CN102037005B CN102037005B (zh) | 2017-03-29 |
Family
ID=40957783
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200880129310.6A Active CN102037005B (zh) | 2008-05-22 | 2008-05-22 | 改善治疗功效的新光学纯化合物 |
Country Status (8)
Country | Link |
---|---|
US (1) | US9243030B2 (zh) |
EP (1) | EP2291390B1 (zh) |
JP (1) | JP5548866B2 (zh) |
CN (1) | CN102037005B (zh) |
AU (1) | AU2008356840B2 (zh) |
BR (1) | BRPI0822661A2 (zh) |
CA (1) | CA2724818C (zh) |
WO (1) | WO2009141687A1 (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356221A (zh) * | 2014-10-24 | 2015-02-18 | 杭州阿德莱诺泰制药技术有限公司 | 一种制备培西加南的方法 |
CN109381362A (zh) * | 2018-12-19 | 2019-02-26 | 浙江神首生物科技有限公司 | 一种焕活生机修复乳液及其制备方法 |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2900341B1 (fr) | 2006-04-27 | 2012-09-14 | Centre Nat Rech Scient | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer |
JP5548866B2 (ja) | 2008-05-22 | 2014-07-16 | サントル ナスィオナル ド ラ ルシェルシュ スィアンティフィク(セ.エン.エル.エス.) | 治療効果の改善のための新規の光学的に純粋な化合物 |
EP2624849A2 (en) | 2010-10-04 | 2013-08-14 | Centre National de la Recherche Scientifique (C.N.R.S.) | Multivalent synthetic compounds as antibiotic treatment |
RU2458663C1 (ru) * | 2010-12-27 | 2012-08-20 | Общество с ограниченной ответственностью предприятие "Репер НН" | Трансплантат для склеропластики |
CN109071602B (zh) * | 2015-11-11 | 2022-09-13 | 西兰制药公司 | 靶向α4β7整联蛋白的环肽 |
WO2018085921A1 (en) | 2016-11-11 | 2018-05-17 | Encycle Therapeutics, Inc. | CYCLIC PEPTIDES MULTIMERS TARGETING α4β7 INTEGRIN |
CN110891964A (zh) | 2017-05-10 | 2020-03-17 | 循环治疗学公司 | 靶向α4β7整合素的均环肽 |
WO2022223544A1 (en) | 2021-04-19 | 2022-10-27 | Centre National De La Recherche Scientifique (Cnrs) | COMBINATION THERAPY OF NUCANT AND mTOR INHIBITORS FOR TREATING CANCER |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007125210A2 (fr) * | 2006-04-27 | 2007-11-08 | Centre National De La Recherche Scientifique (Cnrs) | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer ou de l'inflammation |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL154598B (nl) | 1970-11-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van laagmoleculire verbindingen en van eiwitten die deze verbindingen specifiek kunnen binden, alsmede testverpakking. |
US3817837A (en) | 1971-05-14 | 1974-06-18 | Syva Corp | Enzyme amplification assay |
US3939350A (en) | 1974-04-29 | 1976-02-17 | Board Of Trustees Of The Leland Stanford Junior University | Fluorescent immunoassay employing total reflection for activation |
US3996345A (en) | 1974-08-12 | 1976-12-07 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
US4277437A (en) | 1978-04-05 | 1981-07-07 | Syva Company | Kit for carrying out chemically induced fluorescence immunoassay |
US4275149A (en) | 1978-11-24 | 1981-06-23 | Syva Company | Macromolecular environment control in specific receptor assays |
FR2437213A1 (fr) | 1978-09-28 | 1980-04-25 | Cm Ind | Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation |
US4366241A (en) | 1980-08-07 | 1982-12-28 | Syva Company | Concentrating zone method in heterogeneous immunoassays |
US4957939A (en) | 1981-07-24 | 1990-09-18 | Schering Aktiengesellschaft | Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging |
US4472509A (en) | 1982-06-07 | 1984-09-18 | Gansow Otto A | Metal chelate conjugated monoclonal antibodies |
FR2719049B1 (fr) | 1994-04-22 | 1996-06-14 | Pasteur Institut | Multireprésentation d'un analogue peptidique du substrat de la DPPIV, notamment de type KPR, afin d'inhiber l'entrée du HIV dans les cellules. |
US5891737A (en) | 1995-06-07 | 1999-04-06 | Zymogenetics, Inc. | Combinatorial non-peptide libraries |
US6121236A (en) | 1998-03-24 | 2000-09-19 | The Children's Medical Center Corporation | Multivalent ligands which modulate angiogenesis |
ES2296615T3 (es) | 1999-04-08 | 2008-05-01 | Antisoma Research Limited | Actividad antiproliferativa de oligonucleotidos ricos en g y procedimiento de uso de los mismos para su union a la nucleolina. |
US6783952B1 (en) | 1999-09-16 | 2004-08-31 | Warner-Lambert Company | Secreted soluble α2δ-2, α2δ-3 or α2δ-4 calcium channel subunit polypeptides and screening assays using same |
FR2809960B1 (fr) | 2000-06-07 | 2004-04-23 | Pasteur Institut | Composition adjuvante de la reponse immunitaire comprenant la proteine fha ou un fragment de la proteine fha sous forme libre, et composition immunogene ou vaccinale contenant une telle composition adjuvante |
FR2828207B1 (fr) | 2001-08-02 | 2004-12-24 | Centre Nat Rech Scient | Milieux de reaction pour l'activite thymidylate synthase de la thyx |
US20040002457A1 (en) | 2002-03-12 | 2004-01-01 | Hovanessian Ara V. | Inhibition of virus anchorage by RGG domain of a cell surface-expressed protein, polynucleotide coding for said RGG domain, therapeutic uses thereof by inhibition of microorganism or protein ligand binding to the cell-surface-expressed protein |
US7544767B2 (en) | 2002-04-05 | 2009-06-09 | Burnham Institute For Medical Research | HMGN2 peptides and related molecules that selectively home to tumor blood vessels and tumor cells |
US7357928B2 (en) | 2002-04-08 | 2008-04-15 | University Of Louisville Research Foundation, Inc. | Method for the diagnosis and prognosis of malignant diseases |
FR2840307B1 (fr) | 2002-05-30 | 2006-07-07 | Centre Nat Rech Scient | Nouvelles molecules multimeriques, leur procede de preparation, et leur utilisation pour la preparation de medicaments |
TW200504210A (en) | 2003-07-30 | 2005-02-01 | Chin-Tarng Lin | A nucleolin antisense inhibiting growth of cancer cell |
US20080234464A1 (en) | 2005-04-22 | 2008-09-25 | Hisafumi Ikeda | Compound Having Amino Acid Residue or Peptide Residue and Process for Producing the Same |
DE602007010459D1 (de) | 2007-09-04 | 2010-12-23 | Inst Nat Sante Rech Med | Verwendung von Verbindungen, die die EF-Tu-Nucleolin Wechselwirkung vehindern, zur Verhinderung oder Behandlung von Tularämie |
JP5548866B2 (ja) | 2008-05-22 | 2014-07-16 | サントル ナスィオナル ド ラ ルシェルシュ スィアンティフィク(セ.エン.エル.エス.) | 治療効果の改善のための新規の光学的に純粋な化合物 |
EP2624849A2 (en) | 2010-10-04 | 2013-08-14 | Centre National de la Recherche Scientifique (C.N.R.S.) | Multivalent synthetic compounds as antibiotic treatment |
-
2008
- 2008-05-22 JP JP2011510059A patent/JP5548866B2/ja active Active
- 2008-05-22 EP EP08807467.9A patent/EP2291390B1/en active Active
- 2008-05-22 US US12/993,427 patent/US9243030B2/en active Active
- 2008-05-22 BR BRPI0822661-0A patent/BRPI0822661A2/pt not_active IP Right Cessation
- 2008-05-22 WO PCT/IB2008/053469 patent/WO2009141687A1/en active Application Filing
- 2008-05-22 AU AU2008356840A patent/AU2008356840B2/en active Active
- 2008-05-22 CA CA2724818A patent/CA2724818C/en active Active
- 2008-05-22 CN CN200880129310.6A patent/CN102037005B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007125210A2 (fr) * | 2006-04-27 | 2007-11-08 | Centre National De La Recherche Scientifique (Cnrs) | Utilisation de ligands synthetiques multivalents de la nucleoline de surface pour le traitement du cancer ou de l'inflammation |
Non-Patent Citations (3)
Title |
---|
ADACHI KENICHI ET AL: "Selective BH3-reduction of amide carbonyl groups of lithium salts of N-tert-butoxycarbonyl-(s)-O-benzyltyrosyl-(s)-proline and N,N"-ethylene-bridged dipeptides", 《SYNTHESIS》 * |
CALLEBAUT C. ET AL: "Inhibition of HIV infection by pseudopeptides blocking viral envelop glycoprotein-mediated membrane fusion and celldeath", 《VIROLOGY》 * |
CUSHMAN M. ET AL: "Development of methodology for the synthesis of stereochemically pure pheΨ[CH2N]pro linkages in HIV protease inhibitors", 《JOURNAL OF ORGANIC CHEMISTRY》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104356221A (zh) * | 2014-10-24 | 2015-02-18 | 杭州阿德莱诺泰制药技术有限公司 | 一种制备培西加南的方法 |
CN109381362A (zh) * | 2018-12-19 | 2019-02-26 | 浙江神首生物科技有限公司 | 一种焕活生机修复乳液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CA2724818A1 (en) | 2009-11-26 |
JP5548866B2 (ja) | 2014-07-16 |
CN102037005B (zh) | 2017-03-29 |
EP2291390A1 (en) | 2011-03-09 |
BRPI0822661A2 (pt) | 2015-06-30 |
AU2008356840B2 (en) | 2013-05-16 |
WO2009141687A1 (en) | 2009-11-26 |
JP2011523418A (ja) | 2011-08-11 |
US20110201559A1 (en) | 2011-08-18 |
US9243030B2 (en) | 2016-01-26 |
CA2724818C (en) | 2015-06-16 |
EP2291390B1 (en) | 2014-11-05 |
AU2008356840A1 (en) | 2009-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102037005A (zh) | 改善治疗功效的新光学纯化合物 | |
AU2006266609B2 (en) | Treatment of tumors | |
JP3957751B2 (ja) | 新規ドラスタチン誘導体、その製法及び使用 | |
KR101730680B1 (ko) | 치료용 펩티드 | |
US9415114B2 (en) | Conformations of divergent peptides with mineral binding affinity | |
KR20110022594A (ko) | 신규한 이중 표적화 항종양성 접합체 | |
US20240033318A1 (en) | Peptidyl inhibitors of calcineurin-nfat interaction | |
CN111744020A (zh) | 一种主动靶向响应型多肽药物、其制备方法和应用 | |
JPH02500517A (ja) | ペプチド化合物 | |
US9481712B2 (en) | Peptidomimetics possessing photo-controlled biological activity | |
EP1593686B1 (en) | Antineoplastic peptides | |
AU2020380902A1 (en) | Polypeptide having MMP2-inhibitory effect | |
JP2022518695A (ja) | Caixに特異的な二環式ペプチドリガンド | |
JPH06306096A (ja) | ペプチド誘導体及びその用途 | |
JP3190765B2 (ja) | ペプチド誘導体及びその用途 | |
JPH06298797A (ja) | ペプチド誘導体およびその用途 | |
CN106589064A (zh) | 高活性的肿瘤抑制剂及其制法和应用 | |
US20170051017A1 (en) | Peptidomimetics possessing photo-controlled biological activity | |
TWI535467B (zh) | 具礦質親和能力之多歧狀胜肽構型(一) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB03 | Change of inventor or designer information |
Inventor after: Briand Jean Paul Inventor after: Guichard Gilles Inventor after: Courty Jose Inventor after: Zimmer Robert Inventor after: Devin Chantal Inventor after: A *lang Inventor after: H *zhang Inventor after: Hovanessian Ara Inventor before: Briand Jean Paul Inventor before: Guichard Gilles Inventor before: Courty Jose Inventor before: Zimmer Robert Inventor before: Devin Chantal Inventor before: A *lang Inventor before: H *zhang |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: PAUL BRIAND JEAN GILLES GUICHARD JOSE COURTY ROBERT ZIMMER CHANTAL DEVIN ANNIE LANG ZHANG HUIQING TO: PAUL BRIAND JEAN GILLES GUICHARD JOSE COURTY ROBERT ZIMMER CHANTAL DEVIN ANNIE LANG ZHANG HUIQING ARA HOVANESSIAN |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20180418 Address after: France Co-patentee after: Elro Pharma Patentee after: National Center for scientific research Address before: France Co-patentee before: Immupharma France Patentee before: National Center for scientific research |
|
TR01 | Transfer of patent right |